NCT06520488View on ClinicalTrials.gov

A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

118

Participants

Timeline

Start Date

August 9, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

July 31, 2027

Conditions

Advanced Solid Tumors

Interventions

DRUG

HRS-4642

Treatment group Part I: HRS-4642 combined with SHR-A1921 Treatment group Part II: HRS-4642 combined with SHR-A1904 Treatment group Part II: HRS-4642 combined with AG

Trial Locations (1)

200127

RECRUITING

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY